Advisory Services Network’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Advisory Services Network's ADPT Position: Q2 2026 in Review
Advisory Services Network sold out of Adaptive Biotechnologies (ADPT) in Q2 2026, closing a stake of 65 shares — an estimated $902 sold.
Advisory Services Network first reported a position in ADPT in Q4 2022 and held it in 5 quarters. The position peaked at $972 in Q3 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Advisory Services Network reported no remaining Adaptive Biotechnologies position as of Q2 2026 after selling out during the quarter.
- Advisory Services Network sold 65 Adaptive Biotechnologies shares in Q2 2026, an estimated $902.
- Advisory Services Network first reported a position in Adaptive Biotechnologies in Q4 2022 and held it in 5 quarters.
- Advisory Services Network's Adaptive Biotechnologies position peaked at $972 in Q3 2025.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.